Rating Change
HC Wainwright & Co. reiterated its Buy rating on Voyager Therapeutics, Inc. (NASDAQ:VYGR) on August 10, 2026.
reiterateNASDAQ:VYGR
HC Wainwright & Co. Reiterates Buy Rating on Voyager Therapeutics, Inc. (VYGR)
HC Wainwright & Co. reiterated its Buy rating on Voyager Therapeutics, Inc.
At publication ·
What changed
Voyager Therapeutics, Inc. (NASDAQ:VYGR) · reiterate
- Firm
- HC Wainwright & Co.
- Rating
- Buy to Buy
- Price at event
- $3.17
- Market capitalization
- $245.2M
At a glance
Key takeaways
- HC Wainwright & Co. reiterated a Buy rating on Voyager Therapeutics (VYGR) on August 10, 2026, with the stock trading at $3.17 and a market capitalization of $245.2 million.
Market Context
Voyager Therapeutics, Inc. operates in the Healthcare sector. The stock currently trades at $3.17 with a market capitalization of $245.2M. The stock has declined 1.6% over the past 52 weeks.
Analyst coverage from HC Wainwright & Co. provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Voyager Therapeutics, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Voyager Therapeutics, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 10, 2026 | HC Wainwright & Co. | Buy | N/A |
| Mar 17, 2026 | HC Wainwright & Co. | Buy | N/A |
| Nov 12, 2025 | HC Wainwright & Co. | Buy | N/A |
| Sep 15, 2025 | HC Wainwright & Co. | Buy | N/A |
| Aug 07, 2025 | Wedbush | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View VYGR Stock Page
Frequently Asked Questions
What does the Buy rating mean for VYGR?
A rating of Buy from HC Wainwright & Co. reflects the analyst's outlook on Voyager Therapeutics, Inc. (NASDAQ:VYGR). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the VYGR forecast page.
